Losigamone is an orally active antiepileptic compound; it blocks sodium channels, stimulates neuronal chloride channels, enhances chloride influx, potentiates GABA-mediated responses, and reduces seizure-like activity induced by chloride channel antagonists; it is used in epilepsy research.